697
Views
54
CrossRef citations to date
0
Altmetric
Review

Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?

, PhD

Bibliography

  • Pitkanen A, Engel JJr. Past and present definitions of epileptogenesis and its biomarkers. Neurotherapeutics 2014;11:231-41
  • Dudek FE, Staley KJ. The time course and circuit mechanisms of acquired epileptogenesis. 2012
  • Pitkanen A, Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011;10:173-86
  • Devinsky O, Vezzani A, Najjar S, et al. Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013;36:174-84
  • Filibian M, Frasca A, Maggioni D, et al. In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 2012;53:1907-16
  • Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006;24:128-43
  • Bogdanovic RM, Syvanen S, Michler C, et al. (R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model. Neuropharmacology 2014;85:104-12
  • Boer K, Spliet WG, van Rijen PC, et al. Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol 2006;173:188-95
  • Aronica E, Ravizza T, Zurolo E, et al. Astrocyte immune response in epilepsy. Glia 2012;60:1258-68
  • Ravizza T, Gagliardi B, Noé F, et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008;29:142-60
  • Dedeurwaerdere S, Callaghan PD, Pham T, et al. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Res 2012;2:60
  • Vezzani A, Balosso S, Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803
  • Vezzani A, French J, Bartfai T, et al. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7:31-40
  • Marchi N, Granata T, Janigro D. Inflammatory pathways of seizure disorders. Trends Neurosci 2014;37:55-65
  • Bauer J, Vezzani A, Bien CG. Epileptic encephalitis: the role of the innate and adaptive immune system. Brain Pathol 2012;22:412-21
  • Zattoni M, Mura ML, Deprez F, et al. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci 2011;31:4037-50
  • Fabene PF, Mora GN, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008;14:1377-83
  • Balosso S, Maroso M, Sanchez-Alavez M, et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008;131:3256-65
  • Viviani B, Bartesaghi S, Gardoni F, et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003;23:8692-700
  • Iori V, Maroso M, Rizzi M, et al. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis 2013;58:102-14
  • Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010;16:413-19
  • Balosso S, Liu J, Bianchi ME, et al. Disulfide-Containing High Mobility Group Box-1 Promotes N-Methyl-d-Aspartate Receptor Function and Excitotoxicity by Activating Toll-Like Receptor 4-Dependent Signaling in Hippocampal Neurons. Antioxid Redox Signal 2014;21:1726-40
  • Vezzani A, Moneta D, Conti M, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000;97:11534-9
  • Ravizza T, Lucas SM, Balosso S, et al. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006;47:1160-8
  • Vezzani A, Maroso M, Balosso S, et al. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011;25:1281-9
  • Sellner J, Trinka E. Clinical characteristics, risk factors and pre-surgical evaluation of post-infectious epilepsy. Eur J Neurol 2013;20:429-39
  • Morin-Brureau M, Lebrun A, Rousset MC, et al. Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways. J Neurosci 2011;31:10677-88
  • Balosso S, Ravizza T, Aronica E, et al. The dual role of TNF-alpha and its receptors in seizures. Exp Neurol 2013;247C:267-71
  • Balosso S, Ravizza T, Perego C, et al. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol 2005;57:804-12
  • Weinberg MS, Blake BL, McCown TJ. Opposing actions of hippocampus TNFalpha receptors on limbic seizure susceptibility. Exp Neurol 2013;247:429-37
  • Xiong ZQ, Qian W, Suzuki K, et al. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 2003;23:955-60
  • Aronica E, Boer K, van Vliet EA, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007;26:497-511
  • Jiang J, Ganesh T, Du Y, et al. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proc Natl Acad Sci USA 2012;109:3149-54
  • Rojas A, Jiang J, Ganesh T, et al. Cyclooxygenase-2 in epilepsy. Epilepsia 2014;55:17-25
  • Jiang J, Dingledine R. Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection. Trends Pharmacol Sci 2013;34:413-23
  • van Vliet EA, Zibell G, Pekcec A, et al. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology 2010;58:404-12
  • Bauer B, Hartz AM, Pekcec A, et al. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol 2008;73:1444-53
  • Ravizza T, Balosso S, Vezzani A. Inflammation and prevention of epileptogenesis. Neurosci Lett 2011;497:223-30
  • Henshall DC, Diaz-Hernandez M, Miras-Portugal MT, et al. P2X receptors as targets for the treatment of status epilepticus. Front Cell Neurosci 2013;7:237
  • Mesuret G, Engel T, Hessel EV, et al. P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage. CNS Neurosci Ther 2014;20:556-64
  • Auvin S, Shin D, Mazarati A, et al. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 2010;51(Suppl 3):34-8
  • Marchi N, Fan Q, Ghosh C, et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 2009;33:171-81
  • Vezzani A, Conti M, De Luigi A, et al. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999;19:5054-65
  • Vezzani A, Balosso S, Ravizza T. Inflammation and epilepsy. Handb Clin Neurol 2012;107:163-75
  • Kanner AM, Mazarati A, Koepp M. Biomarkers of epileptogenesis: psychiatric comorbidities (?). Neurotherapeutics 2014;11:358-72
  • Vezzani A, Aronica E, Mazarati A, et al. Epilepsy and brain inflammation. Exp Neurol 2013;244:11-21
  • Rizzi M, Perego C, Aliprandi M, et al. Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 2003;14:494-503
  • Marcon J, Gagliardi B, Balosso S, et al. Age-dependent vascular changes induced by status epilepticus in rat forebrain: implications for epileptogenesis. Neurobiol Dis 2009;34:121-32
  • Choy M, Dubé CM, Patterson K, et al. A novel, noninvasive, predictive epilepsy biomarker with clinical potential. J Neurosci 2014;34:8672-84
  • Dubé CM, Ravizza T, Hamamura M, et al. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 2010;30:7484-94
  • Friedman A, Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 2011;52(Suppl 3):33-9
  • Steinhauser C, Seifert G, Bedner P. Astrocyte dysfunction in temporal lobe epilepsy: K+ channels and gap junction coupling. Glia 2012;60:1192-202
  • Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on excitotoxicity. Neuropharmacology 2014;10.1016/j.neuropharm.2014.10.027
  • Librizzi L, Noé F, Vezzani A, et al. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 2012;72:82-90
  • Frigerio F, Frasca A, Weissberg I, et al. Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia 2012;53:1887-97
  • Heinemann U, Kaufer D, Friedman A. Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia 2012;60:1251-7
  • Choi J, Nordli DRJr, Alden TD, et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009;6:38
  • Mikati MA, Kurdi R, El-Khoury Z, et al. Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature. Epilepsy Behav 2010;17:90-4
  • Gayatri N, Ferrie CD, Cross H. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. Cochrane Database Syst Rev 2009(3):CD005222
  • Rho JM, Stafstrom CE. The ketogenic diet: what has science taught us? Epilepsy Res 2012;100:210-17
  • Bonaz B, Picq C, Sinniger V, et al. Vagus nerve stimulation: from epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol Motil 2013;25:208-21
  • Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol 2009;24:979-88
  • Klein P, Tyrlikova I, Mathews GC. Dietary treatment in adults with refractory epilepsy: a review. Neurology 2014;83:1978-85
  • Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5:553-64
  • Vezzani A, Balosso S, Maroso M, et al. ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. Curr Opin Investig Drugs 2010;11:43-50
  • Cornelis S, Kersse K, Festjens N, et al. Inflammatory caspases: targets for novel therapies. Curr Pharm Des 2007;13:367-85
  • Fleischmann RM, Tesser J, Schiff MH, et al. Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1006-12
  • Fleishmann RM. Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents. Clin Exp Rheumatol 2002;20:S35-41
  • Varvel NH, Jiang J, Dingledine R. Candidate drug targets for prevention or modification of epilepsy. Annu Rev Pharmacol Toxicol 2015;55:229-47
  • Noé FM, Polascheck N, Frigerio F, et al. Pharmacological blockade of IL-1beta/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis 2013;59:183-93
  • Clausen F, Hanell A, Bjork M, et al. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci 2009;30:385-96
  • Ma L, Cui XL, Wang Y, et al. Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats. Brain Res 2012;1469:103-13
  • van Vliet EA, Aronica E, Gorter JA. Blood-brain barrier dysfunction, seizures and epilepsy. Semin Cell Dev Biol 2014;10.1016/j.semcdb.2014.10.003
  • Giza CC, Kolb B, Harris NG, et al. Hitting a moving target: basic mechanisms of recovery from acquired developmental brain injury. Dev Neurorehabil 2009;12:255-68
  • Simonato M, Brooks-Kayal AR, Engel JJr, et al. The challenge and promise of anti-epileptic therapy development in animal models. Lancet Neurol 2014;13:949-60
  • Vezzani A, Friedman A. Brain inflammation as a biomarker in epilepsy. Biomark Med 2011;5:607-14
  • Hirvonen J, Kreisl W, Fujita M, et al. Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. American Epilepsy Society, S Antonio (TX) 2010;abstract 3230
  • Harhausen D, Sudmann V, Khojasteh U, et al. Specific imaging of inflammation with the 18 kDa translocator protein ligand DPA-714 in animal models of epilepsy and stroke. PLoS One 2013;8:e69529
  • Nag S, Lehmann L, Kettschau G, et al. Synthesis and evaluation of [(1)(8)F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B). Bioorg Med Chem 2012;20:3065-71
  • Gauberti M, Montagne A, Quenault A, et al. Molecular magnetic resonance imaging of brain-immune interactions. Front Cell Neurosci 2014;8:389
  • Duffy BA, Choy M, Riegler J, et al. Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent. Neuroimage 2012;60:1149-55
  • Kobow K, Blumcke I. Epigenetic mechanisms in epilepsy. Prog Brain Res 2014;213:279-316

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.